» Articles » PMID: 26493698

Review of the Uses of Vagal Nerve Stimulation in Chronic Pain Management

Overview
Date 2015 Oct 24
PMID 26493698
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Recent human and animal studies provide growing evidence that vagal nerve stimulation (VNS) can deliver strong analgesic effects in addition to providing therapeutic efficacy in the treatment of refractory epilepsy and depression. Analgesia is potentially mediated by vagal afferents that inhibit spinal nociceptive reflexes and transmission and have strong anti-inflammatory properties. The purpose of this review is to provide pain practitioners with an overview of VNS technology and limitations. It specifically focuses on clinical indications of VNS for various chronic pain syndromes, including fibromyalgia, pelvic pain, and headaches. We also present potential mechanisms for VNS modulation of chronic pain by reviewing both animal and human studies.

Citing Articles

Pain and the autonomic nervous system. The role of non-invasive neuromodulation with NESA microcurrents.

Azevedo N, Medina-Ramirez R Front Pain Res (Lausanne). 2025; 6:1410808.

PMID: 40034400 PMC: 11873094. DOI: 10.3389/fpain.2025.1410808.


Transcutaneous vagus nerve stimulation as a pain modulator in knee osteoarthritis: a randomized controlled clinical trial.

Elsehrawy G, Ibrahim M, A Moneim N, Hefny M, El Shaarawy N BMC Musculoskelet Disord. 2025; 26(1):68.

PMID: 39828740 PMC: 11744843. DOI: 10.1186/s12891-025-08288-6.


Advances in VNS efficiency and mechanisms of action on cognitive functions.

Wang W, Li R, Li C, Liang Q, Gao X Front Physiol. 2024; 15:1452490.

PMID: 39444752 PMC: 11496278. DOI: 10.3389/fphys.2024.1452490.


Transcutaneous vagus nerve stimulation effects on chronic pain: systematic review and meta-analysis.

Costa V, Gianlorenco A, Andrade M, Camargo L, Menacho M, Avila M Pain Rep. 2024; 9(5):e1171.

PMID: 39131814 PMC: 11309651. DOI: 10.1097/PR9.0000000000001171.


Using neural biomarkers to personalize dosing of vagus nerve stimulation.

Berthon A, Wernisch L, Stoukidi M, Thornton M, Tessier-Lariviere O, Fortier-Poisson P Bioelectron Med. 2024; 10(1):15.

PMID: 38880906 PMC: 11181600. DOI: 10.1186/s42234-024-00147-4.


References
1.
Randich A, Ren K, Gebhart G . Electrical stimulation of cervical vagal afferents. II. Central relays for behavioral antinociception and arterial blood pressure decreases. J Neurophysiol. 1990; 64(4):1115-24. DOI: 10.1152/jn.1990.64.4.1115. View

2.
Ammons W, Blair R, Foreman R . Vagal afferent inhibition of primate thoracic spinothalamic neurons. J Neurophysiol. 1983; 50(4):926-40. DOI: 10.1152/jn.1983.50.4.926. View

3.
Ben-Menachem E . Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2003; 1(8):477-82. DOI: 10.1016/s1474-4422(02)00220-x. View

4.
Randich A, Gebhart G . Vagal afferent modulation of nociception. Brain Res Brain Res Rev. 1992; 17(2):77-99. DOI: 10.1016/0165-0173(92)90009-b. View

5.
Cechetto D . Central representation of visceral function. Fed Proc. 1987; 46(1):17-23. View